Revision of Prior Period Financial Statements

3 Months Ended

12 Months Ended

Mar. 31, 2021

Dec. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Revision of Prior Period Financial Statements

15. Revision of Prior Period Financial Statements

During the audit for the year ended December 31, 2020 an error was discovered relating to share issuances resulting from an anti-dilution agreement. The share issuances for the three months ended March 31, 2020 were 2,000,000 and 458,834 common shares respectively. The anti-dilution agreement relating to a 2017 share subscription payable agreement was triggered in March 2019 upon the Company’s stock split.

We revised certain prior period financial statements for an immaterial error related to the recognition of the deemed dividend related to down-round features along with the associated shares issuance and professional fees (note 1). A summary of revisions to our previously reported financial statements presented herein for comparative purposes.

The cumulative effect of the adjustments on all prior periods to Shareholders’ Equity as of March 31, 2020 reflected below:

	Common Stock				Additional Paid-in Capital		Share Subscriptions Receivable			Share Subscription Payable		Accumulated Deficit			Cumulative translation adjustment			Total Stockholders’ Equity (Deficit)
	Shares		Amount
Balance at March 31, 2020		46,547,749	$	4,655	$	9,060,739	$	(1,577	)	$	1,178,608	$	(10,961,172	)	$	(8,580	)	$	(727,327	)
Revision		2,458,834	$	246	$	731,946		-		$	137,315	$	(869,507	)		-			-
Balance at March 31, 2020, as revised		49,006,583	$	4,901	$	9,792,685	$	(1,577	)	$	1,315,923	$	(11,830,679	)	$	(8,580	)	$	(727,327	)

The Condensed Consolidated Statements of Operations has been revised to reflect the correction for the three months ended March 31, 2020 as follows:

	For the Three Months Ended March 31, 2020
	As previously reported			Revision			As Revised
Professional Fees	$	149,465		$	(40,000	)	$	109,465
Total Operating Expenses	$	178,471		$	(40,000	)	$	138,471
Loss from Operations	$	(164,455	)	$	40,000		$	(124,455	)
Net Loss	$	(192,266	)	$	40,000		$	(152,266	)
Comprehensive Loss	$	(192,266	)	$	40,000		$	(152,266	)
Loss per Share – Basic and Diluted	$	(0.00	)		-		$	(0.00	)

23. Revision of Prior Period Financial Statements

During the audit for the year ended December 31, 2020 an error was discovered relating to share issuances resulting from an anti-dilution agreement. The share issuances for the three months ended March 31, 2020 were 2,000,000 and 458,834 shares of common stock respectively. The anti-dilution agreement relating to a 2017 share subscription payable agreement was triggered in March 2019 upon the Company’s stock split. Please refer to note 9.

We revised certain prior period financial statements for an immaterial error related to the recognition of the deemed dividend related to

down-round features along with the associated shares issuance and professional fees (Note 1). A summary of revisions to our previously reported financial statements presented herein for comparative purposes.

The cumulative effect of the adjustments on all prior periods to Shareholders’ Equity as of June 30, 2019, September 30, 2019, December 30, 2019 and March 31, 2020 reflected below:

	Common Stock				Additional Paid-in Capital		Share Subscriptions Receivable			Share Subscription Payable		Accumulated Deficit			Cumulative translation adjustment			Total Stockholders’ Equity (Deficit)
	Shares		Amount
Balance at June 30, 2019		28,177,966	$	2,817	$	8,309,293	$	(1,577	)	$	1,853,819	$	(10,482,521	)	$	(23,624	)	$	(341,792	)
Revision		12,719,566	$	1,273	$	182,509		-		$	781,298	$	(965,079	)		-			-
Balance at June 30, 2019, as revised		40,897,532	$	4,090	$	8,491,802	$	(1,577	)	$	2,635,117	$	(11,447,600	)	$	(23,624	)	$	(341,792	)
Balance at September, 2019		38,506,721	$	3,850	$	8,230,982	$	(1,577	)	$	1,606,097	$	(10,212,150	)	$	(46,116	)	$	(418,915	)
Revision		1,400,069	$	141	$	183,641		-		$	781,298	$	(965,079	)		-			-
Balance at September 30, 2019, as revised		39,906,790	$	3,991	$	8,414,623	$	(1,577	)	$	2,387,395	$	(11,177,230	)	$	(46,116	)	$	(418,915	)
Balance at December 31, 2019		41,906,790	$	4,191	$	8,381,231	$	(1,577	)	$	1,511,080	$	(10,768,906	)	$	(8,580	)	$	(882,561	)
Revision		-		-	$	261,192		-		$	648,315	$	(909,507	)		-			-
Balance at December 31, 2019, as revised		41,906,790	$	4,191	$	8,642,423	$	(1,577	)	$	2,159,395	$	(11,678,413	)	$	(8,580	)	$	(882,561	)
								-
Balance at March 31, 2020		46,547,749	$	4,655	$	9,060,739	$	(1,577	)	$	1,178,608	$	(10,961,172	)	$	(8,580	)	$	(727,327	)
Revision		2,458,834	$	246	$	731,946		-		$	137,315	$	(869,507	)		-			-
Balance at March 31, 2020, as revised		49,006,583	$	4,901	$	9,792,685	$	(1,577	)	$	1,315,923	$	(11,830,679	)	$	(8,580	)	$	(727,327	)

The Consolidated Statements of Operations and Comprehensive Loss has been revised to reflect the correction for the year ended December 31, 2019 and three months ended March 31, 2020 as follows:

	For the Year Ended December 31, 2019
	As previously reported			Revision			As Revised
Professional Fees	$	570,852		$	(55,573	)	$	515,279
Total Operating Expenses	$	831,971		$	(55,573	)	$	776,398
Loss from Operations	$	(593,424	)	$	(55,573	)	$	(537,851	)
Net Loss	$	(414,607	)	$	(55,573	)	$	(359,034	)
Comprehensive Loss	$	(419,574	)	$	(55,573	)	$	(364,001	)
Loss per Share–Basic and Diluted	$	(0.01	)		-		$	(0.01	)

	For the Three Months Ended March 31, 2020
	As previously reported			Revision			As Revised
Professional Fees	$	149,465		$	(40,000	)	$	109,465
Total Operating Expenses	$	178,471		$	(40,000	)	$	138,471
Loss from Operations	$	(164,455	)	$	40,000		$	(124,455	)
Net Loss	$	(192,266	)	$	40,000		$	(152,266	)
Comprehensive Loss	$	(192,266	)	$	40,000		$	(152,266	)
Loss per Share–Basic and Diluted	$	(0.00	)		-		$	(0.00	)